# Imjudo & Imfinzi PMS

> **NCT06544629** · — · RECRUITING · sponsor: **AstraZeneca** · enrollment: 246 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06544629
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-14
- **Primary completion:** 2029-02-28
- **Final completion:** 2029-02-28
- **Target enrollment:** 246 (ESTIMATED)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06544629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06544629, "Imjudo & Imfinzi PMS". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT06544629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*